Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc., formerly associated with blank-check vehicle Leisure Acquisition Corp. (Nasdaq: LACQ), filed an 8-K with the Securities and Exchange Commission on May 15, 2026, bearing accession number 0001493152-26-023810. LACQ completed its initial public offering in 2019 under the sponsorship of Hydra Management LLC, originally targeting the leisure and entertainment sector before completing a business combination with Ensysce, a pharmaceutical company focused on abuse-deterrent drug formulations. The combined entity, Ensysce Biosciences, operates in the life sciences and specialty pharmaceuticals industry as a post-combination public company. Visit SpacDesk and sign up for full data, filings history, and deal analytics on this and hundreds of other SPAC transactions.